Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
Bupa to acquire Australian and New Zealand dentistry group

Bupa plans to acquire Australia and New Zealand-based Dental Corporation for AUD$374 million (£244 million).

The deal is expected to complete in March 2013 and will see Bupa acquire 100% of the shares in the firm.

The purchase price is 84% of the company’s value, with the remaining 16% payable to the dentists and management team over a three-year period.

Dean Holden, managing director of Bupa Australia and New Zealand, said: “We’re really excited by this acquisition and look forward to working with Dental Corporation’s management team and its dentists to build on their track record of growth and success.”

Dental Corporation is Australia and New Zealand’s largest dental group, with 190 clinics and more than 560 dentists.

This follows Bupa’s announcement in July 2012 of a multi-million pound investment in UK dental services. It plans to open up to 50 additional private dental centres over the next three years.

Posted on: 17/12/2012

Latest news stories

03/07/2020
The number of people considering paying for private treatment or health insurance has significantly increased since the Covid-19 outbreak, despite the impact of the pandemic on personal finances, according to new research.
01/07/2020
Researchers from King’s Business School say that the care sector needs a new model of employment relations to tackle the challenges exposed by the Covid-19 crisis.
01/07/2020
The number of deals announced in the global healthcare sector fell by 12% during the week ended June 28, according to GlobalData’s deals database
30/06/2020
Health leaders have voiced concerns that the government’s messaging on pandemic mitigation is “clouded in confusion”.
30/06/2020
Beckley Psytech has raised £3m of Series A funding to develop a pipeline of psychedelic drugs into licensed pharmaceutical medicines for treating psychiatric and neurological diseases.



HealthInvestor blog
April was indeed the cruellest month, to paraphrase T.S.Eliot. The tragedy of so many lives lost will resonate for decades and we will long remember the bitter chill from the sinister shadow of Covid-19.

Click here to view the HealthInvestor blog


We could be forgiven for failing to remember that Brexit happened just four short months ago but the implications for the sector are still very much here to stay. Marie Manley and Will Holmes, of Sidley Austin investigate the future for life sciences
Helen Costa is the founder of Cornerstone, a social enterprise focused on improving the lives of children and families touched by the care system. She talks to Jenna Lomax about challenging the consultancy industry and how virtual reality can improve vulnerable lives
Helen Nugent, a barrister in the clinical negligence team at Temple Garden Chambers, outlines what operators need to know about the provision and use of PPE at a time of crisis
With the technologies now available to us, there is no reason government initiatives to track and control the spread of Covid-19 must come at the expense of personal data privacy, writes R3’s Isabelle Corbett
The Covid-19 outbreak has had a significant impact on the UK healthcare real estate investment market. Kathy Oxtoby reviews the landscape

Click here to search all feature articles


my images

Social care

Helen Costa is the founder of Cornerstone, a social enterprise focused on improving the lives of children and families touched by the care system. She talks to Jenna Lomax about challenging the consultancy industry and how virtual reality can improve vulnerable lives
Read more


Christie + Co


Investment amid Covid-19
The Covid-19 virus has put the fragility of the global economic system under the microscope. But Jenna Lomax finds out why some leading industry figures believe the healthcare sector will be able to quickly bounce back from the economic freeze
Read more